Viekira XR and Technivie Fact Sheet

Viekira XR is a combination of hepatitis C virus–fighting drugs (paritaprevir/ritonavir/ombitasvir and dasabuvir) that block different steps of the virus life cycle. In the United States, Viekira XR is approved for people with hepatitis C genotype 1 who are over 18 years old. Viekira XR was previously approved and prescribed as a twice a day formula known as Viekira Pak. XR contains the same drugs, in the same amounts, as Viekira Pak, now in a once daily package.


Attached documents

Viekira XR and Technivie Fact Sheet

PDF – 61.9 kb